Waltenbaugh C
J Exp Med. 1981 Nov 1;154(5):1570-83. doi: 10.1084/jem.154.5.1570.
Using a novel, two-step functional screening procedure, we have isolated hybridoma B cell lines secreting monoclonal antibodies directed against gene products of the I-Jb and I-Jk subregions of the mouse H-2 complex. These monoclonal antibodies act in vitro by allowing nonresponder spleen cells to respond to normally suppressive quantities of poly(Glu50Tyr50) (GT) (WF8 series of anti-I-Jk monoclonal antibodies) or to suboptimal concentration of poly(Glu60Ala30Tyr10) (WF9 series of anti-I-Jb monoclonal antibodies). Some of the culture supernates that show augmenting activity bind GT-specific T cell-derived suppressor factor (GT-TsF), indicating that some monoclonal antiantibodies display a nonspecific enhancing effect, or, more likely, that anti-I-J monoclonal antibodies have been produced against I-J determinants not found on TsF. It is this last possibility that is most intriguing and that might serve as a means for exploring the heterogeneity of the I-J subregion. It is also possible that some of our monoclonal anti-I-J antibodies might detect antigenic determinants selectively expressed on suppressor T cells, helper T cells, and/or macrophages. In addition, we have demonstrated that monoclonal anti-I-J antibodies should be useful in the biochemical characterization and purification of a monoclonal GT-TsF. These haplotype-specific anti-I-J monoclonal antibodies should prove to be powerful tools for future studies exploring the role of I-J gene products in the regulation of specific immune responses.
通过一种新颖的两步功能筛选程序,我们分离出了分泌针对小鼠H-2复合体I-Jb和I-Jk亚区基因产物的单克隆抗体的杂交瘤B细胞系。这些单克隆抗体在体外发挥作用,使无反应性脾细胞能够对正常抑制量的聚(谷氨酸50酪氨酸50)(GT)(WF8系列抗I-Jk单克隆抗体)或次优浓度的聚(谷氨酸60丙氨酸30酪氨酸10)(WF9系列抗I-Jb单克隆抗体)作出反应。一些显示增强活性的培养上清液能结合GT特异性T细胞衍生的抑制因子(GT-TsF),这表明一些单克隆抗体表现出非特异性增强作用,或者更有可能的是,所产生的抗I-J单克隆抗体是针对TsF上未发现的I-J决定簇。正是最后一种可能性最具吸引力,并且可能成为探索I-J亚区异质性的一种手段。也有可能我们的一些抗I-J单克隆抗体可能检测到在抑制性T细胞、辅助性T细胞和/或巨噬细胞上选择性表达的抗原决定簇。此外,我们已经证明单克隆抗I-J抗体在单克隆GT-TsF的生化特性鉴定和纯化中应该是有用的。这些单倍型特异性抗I-J单克隆抗体应该被证明是未来研究探索I-J基因产物在特异性免疫反应调节中作用的有力工具。